Folgen
Nathan D. Price
Titel
Zitiert von
Zitiert von
Jahr
Genome-scale models of microbial cells: evaluating the consequences of constraints
ND Price, JL Reed, BØ Palsson
Nature Reviews Microbiology 2 (11), 886-897, 2004
12952004
A community-driven global reconstruction of human metabolism
I Thiele, N Swainston, RMT Fleming, A Hoppe, S Sahoo, MK Aurich, ...
Nature biotechnology 31 (5), 419-425, 2013
12062013
Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease
R Sims, SJ Van Der Lee, AC Naj, C Bellenguez, N Badarinarayan, ...
Nature genetics 49 (9), 1373-1384, 2017
9532017
Multiple early factors anticipate post-acute COVID-19 sequelae
Y Su, D Yuan, DG Chen, RH Ng, K Wang, J Choi, S Li, S Hong, R Zhang, ...
Cell 185 (5), 881-895. e20, 2022
9232022
The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models
L Shi, G Campbell, WD Jones, F Campagne, Z Wen, SJ Walker, Z Su, ...
Nature biotechnology 28 (8), 827-838, 2010
8782010
Mapping the human genetic architecture of COVID-19
Writing group Writing group leaders Pathak Gita A. 6 Andrews Shea J. 7 Kanai ...
Nature 600 (7889), 472-477, 2021
7942021
P4 medicine: how systems medicine will transform the healthcare sector and society
M Flores, G Glusman, K Brogaard, ND Price, L Hood
Personalized medicine 10 (6), 565-576, 2013
7362013
Multiscale analysis of independent Alzheimer’s cohorts finds disruption of molecular, genetic, and clinical networks by human herpesvirus
B Readhead, JV Haure-Mirande, CC Funk, MA Richards, P Shannon, ...
Neuron 99 (1), 64-82. e7, 2018
6632018
Health and disease markers correlate with gut microbiome composition across thousands of people
O Manor, CL Dai, SA Kornilov, B Smith, ND Price, JC Lovejoy, ...
Nature communications 11 (1), 5206, 2020
5962020
Genome-scale microbial in silico models: the constraints-based approach
ND Price, JA Papin, CH Schilling, BO Palsson
Trends in biotechnology 21 (4), 162-169, 2003
5352003
Multi-omics resolves a sharp disease-state shift between mild and moderate COVID-19
Y Su, D Chen, D Yuan, C Lausted, J Choi, CL Dai, V Voillet, VR Duvvuri, ...
Cell 183 (6), 1479-1495. e20, 2020
5282020
Comparison of network-based pathway analysis methods
JA Papin, J Stelling, ND Price, S Klamt, S Schuster, BO Palsson
Trends in biotechnology 22 (8), 400-405, 2004
4992004
Probabilistic integrative modeling of genome-scale metabolic and regulatory networks in Escherichia coli and Mycobacterium tuberculosis
S Chandrasekaran, ND Price
Proceedings of the National Academy of Sciences 107 (41), 17845-17850, 2010
4952010
Metabolic pathways in the post-genome era
JA Papin, ND Price, SJ Wiback, DA Fell, BO Palsson
Trends in biochemical sciences 28 (5), 250-258, 2003
4552003
Isoforms of RNA-editing enzyme ADAR1 independently control nucleic acid sensor MDA5-driven autoimmunity and multi-organ development
K Pestal, CC Funk, JM Snyder, ND Price, PM Treuting, DB Stetson
Immunity 43 (5), 933-944, 2015
4512015
Evolution of translational omics: lessons learned and the path forward
Committee on the Review of Omics-Based Tests for Predicting Patient Outcomes ...
National Academies Press, 2012
4292012
Gut microbiome pattern reflects healthy ageing and predicts survival in humans
T Wilmanski, C Diener, N Rappaport, S Patwardhan, J Wiedrick, ...
Nature metabolism 3 (2), 274-286, 2021
4262021
A wellness study of 108 individuals using personal, dense, dynamic data clouds
ND Price, AT Magis, JC Earls, G Glusman, R Levy, C Lausted, ...
Nature biotechnology 35 (8), 747-756, 2017
3912017
IL-10 alters immunoproteostasis in APP mice, increasing plaque burden and worsening cognitive behavior
P Chakrabarty, A Li, C Ceballos-Diaz, JA Eddy, CC Funk, B Moore, ...
Neuron 85 (3), 519-533, 2015
3902015
MEMOTE for standardized genome-scale metabolic model testing
C Lieven, ME Beber, BG Olivier, FT Bergmann, M Ataman, P Babaei, ...
Nature biotechnology 38 (3), 272-276, 2020
3872020
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20